Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Note on glycosaminoglycans]

A Lattanzi1

  • 1Ospedale S. Chiara di Pisa.

La Clinica Terapeutica
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

This review discusses glycosaminoglycans (GAGs), including standard heparin and low molecular weight heparins (LMWH). It covers their therapeutic uses, properties, and comparisons, along with other GAGs in endothelium and joints.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of pulsatility on particle dispersion in expiratory flows.

Physics of fluids (Woodbury, N.Y. : 1994)·2021
Same author

Breast cancer in European Union: an update of screening programmes as of March 2014 (review).

International journal of oncology·2014
Same author

Colorectal cancer prevention in Europe: burden of disease and status of screening programs.

Preventive medicine·2014
Same author

Randomized trial to evaluate cardiometabolic and endothelial function in patients with plasma HIV-1 RNA suppression switching to darunavir/ritonavir with or without nucleoside analogues.

HIV clinical trials·2013
Same author

The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600).

British journal of cancer·2010
Same author

Handgrip impairment in Charcot-Marie-Tooth disease.

Europa medicophysica·2005
Same journal

Effectiveness of Focal Muscle Vibration in Post-Anterior Cruciate Ligament Reconstruction Rehabilitation: A Case Report.

La Clinica terapeutica·2026
Same journal

Violence Against Women as a Public-Health Exposure: Biological Embedding, Medico-Legal Caution and Precision Prevention in the EpiWe Framework.

La Clinica terapeutica·2026
Same journal

Suicide of the Work-Disabled Individual Affected by Neoplasia with Unfavorable Prognosis: Evidence-Based Legal Medicine in Reconstructing the Causal Link.

La Clinica terapeutica·2026
Same journal

The therapeutic potential of N-acetylcysteine across multiple organ systems: a narrative review.

La Clinica terapeutica·2026
Same journal

Mesotherapy in Pain Management in Primary Care: A Narrative Review and Practice-Oriented Appraisal.

La Clinica terapeutica·2026
Same journal

Bone Marrow Edema in Rheumatic Diseases: Incidence, Diagnosis, and Therapeutic Implications. A Narrative Review.

La Clinica terapeutica·2026
See all related articles

Area of Science:

  • Biochemistry and Pharmacology
  • Glycosaminoglycan (GAG) structure and function
  • Therapeutic applications of anticoagulants

Background:

  • Overview of glycosaminoglycans (GAGs) chemical structure.
  • Established therapeutic roles of standard heparin in anticoagulation and antithrombosis.
  • Need for understanding alternative GAG derivatives.

Purpose of the Study:

  • To illustrate the properties and therapeutic employment of low molecular weight heparins (LMWH).
  • To compare LMWH with standard heparin, detailing advantages and disadvantages.
  • To describe characteristics and therapeutic properties of heparan sulfates and other GAGs in vascular endothelium and articular structures.

Main Methods:

  • Literature review and synthesis of existing data on GAGs.

Related Experiment Videos

  • Comparative analysis of standard heparin and LMWH.
  • Description of GAGs from specific biological locations (endothelium, joints).
  • Main Results:

    • Detailed exposition of LMWH properties and clinical applications.
    • Comparative efficacy and safety profile of LMWH versus standard heparin.
    • Characterization of endothelial and articular GAGs and their therapeutic potential.

    Conclusions:

    • LMWH offers distinct advantages over standard heparin in certain therapeutic contexts.
    • Heparan sulfates and other GAGs possess significant therapeutic properties.
    • Further research into diverse GAGs may yield novel therapeutic strategies.